Menarini Diagnósticos, S.A Company Profile
Menarini Diagnósticos, S.A., es una sociedad inscrita en el Registro Mercantil de Barcelona, Tomo 3.947, Folio 241, Sección 2ª, Hoja 42.100, con CIF a-08-534.638 Esta empresa es propietaria del nombre de dominio www.diabetesmenarini.com
Location
Avda. del Maresme 120,
Badalona
Barcelona
08918
Spain
Contact
Phone: 93-507.10.00
Email: protecciondatos@menarinidiag.es
News Articles
Invida Rebrands to Menarini Asia-Pacific
Invida has changed its name to Menarini Asia-Pacific effective immediately, to reflects its alignment with parent, Menarini Group.
Menarini Partners on Cancer ADCs for $1 Billion
Show some success in medicine and others will follow. Genentech's soon to be licensed T-DM1 for the treatment of breast cancer has spawned many other entrants pouring into the ADC field. The latest to...
Menarini Partners on Cancer ADCs for $1B
Show some success in medicine and others will follow. Genentech's soon to be licensed T-DM1 for the treatment of breast cancer has spawned many other entrants pouring into the ADC field. The latest to...
Menarini, Oxford BioTherapeutics in cancer deal
Oxford BioTherapeutics Ltd. (Abingdon, U.K.) partnered with Menarini Group (Florence, Italy) to develop five of Oxford's antibody and antibody-drug conjugate (ADC) programs for undisclosed cancer indi...
Menarini to pay Furiex for Priligy launch in France
The Menarini Group will make a milestone payment worth $5m to Furiex Pharmaceuticals for launching Priligy in France.
Menarini and Oxford BioTherapeutics ink $1 billion cancer pact
Menarini and Oxford BioTherapeutics announce a major innovative and strategic alliance to develop a portfolio of antibody-based drugs in the field of cancer.The agreement covers five of antibody and a...
Menarini earmarks €800m for onco ADCs from Oxford BioTherapeutics
Menarini is reconfirming its biotech ambitions by pledging to commit around €800 million in the next 10 years in five antibody programs it is accessing from Oxford BioTherapeutics. The announce...
Oxford, Menarini join forces to develop antibody-based cancer drugs
Oxford BioTherapeutics and Menarini agreed to jointly develop antibody-based oncology drugs, and the deal will cover five of -More-
Drugs and Medications
None
PubMed Articles
Attributing Fuzzy Values to Nursing Diagnoses and Their Elements: The Specialists' Opinion.
PURPOSE: To test the viability of to use specialists' opinions to establish degrees of membership between nursing diagnoses and its elements (defining characteristics or risk factors), based on the co...
Spiritual Distress-Proposing a New Definition and Defining Characteristics.
OBJECTIVE: To identify the definition and defining characteristics (DCs) of spiritual distress (00066). METHOD: Integrative literature review. RESULTS: Thirty-seven articles and 35 DCs were identified...
Evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser for HbA(1c).
Abstract Background: We report an evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser (HA-8180V), the fifth generation Menarini/ARKRAY ion-exchange HPLC for the measurement of HbA(1c). Metho...
CT Coronary Calcification: What Does a Score of "0" Mean?
Calcium score (CS) is a useful tool in evaluating the risk of cardiovascular events in asymptomatic patients. The absence of detectable calcification determines excellent cardiovascular prognosis, wit...
Clinical Trials
None
Companies
Menarini Diagnósticos, S.A., es una sociedad inscrita en el Registro Mercantil de Barcelona, Tomo 3.947, Folio 241, Sección 2ª, Hoja 42.100, con CIF a-08-534.638 Esta empresa es propietaria del nom...
A Dialab Diagnósticos é a representante exclusiva no Brasil dos produtos Promega, uma das empresas lÃderes mundiais no mercado de produtos bio-farmacêuticos e de ciências da vida. Em seu contÃnu...
BERLIN-CHEMIE develops, produces and markets pharmaceutical products. BERLIN-CHEMIE AG is part of the global MENARINI GROUP, which is headquartered in Florence/Italy. MENARINI is the largest Italian p...
En 1986 un grupo de jóvenes pero sólidos profesionales iniciaron EL PROYECTO DIAGNÓSTICO MAIPÚ. Sus objetivos, con la consigna del progreso y la excelencia, fueron: • Consolidar una InstituciÃ...
Nemo es una empresa española ubicada en Cataluña (Baix Penedès) lÃÂder en la fabricación de componentes plásticos para la Industria Farmacéutica. Especializada en la inyección d...
More Information about "Menarini Diagnósticos, S.A" on BioPortfolio
We have published hundreds of Menarini Diagnósticos, S.A news stories on BioPortfolio along with dozens of Menarini Diagnósticos, S.A Clinical Trials and PubMed Articles about Menarini Diagnósticos, S.A for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Menarini Diagnósticos, S.A Companies in our database. You can also find out about relevant Menarini Diagnósticos, S.A Drugs and Medications on this site too.
